Ba. Bjornbeth et al., Effect of intravenous bilirubin infusion on biliary phospholipid secretion, hepatic P-glycoprotein expression, and biliary cytotoxicity in pigs, SC J GASTR, 34(10), 1999, pp. 1042-1049
Background: Infusion of large intravenous bilirubin loads in bile acid-depl
eted pigs reduces P-glycoprotein-dependent biliary phospholipid secretion a
nd increases the cytotoxicity of bile. The reasons for the diminution of bi
liary phospholipid secretion and the increase in biliary cytotoxicity are n
ot known. This study was undertaken to determine whether the bilirubin-indu
ced lowering of biliary phospholipid secretion is associated with alteratio
ns in hepatic P-glycoprotein (P-gp) expression and to determine why bilirub
in infusions increase biliary cytotoxicity. Methods: Hepatic bile was colle
cted from bile acid-depleted pigs before and during intravenous bilirubin i
nfusion. Hepatic P-gp expression was measured with protein blot analysis, u
sing the P-gp-specific antibody C219. Biliary cytotoxicity was assayed agai
nst erythrocytes. The biliary phospholipid fatty acid profile was determine
d by means of gas chromatography. Results: Bilirubin infusions lowered bili
ary phospholipid secretion by 69% without changing hepatic P-gp expression,
suggesting that bilirubin infusions have an inhibitory effect on hepatic P
-gp activity. Bilirubin infusions did not cause P-gp losses into bile. An u
nequivocal, proportional relationship (r(2) = 0.80) pertained between cytot
oxicity and the bile acid to phospholipid ratio in bile secreted before and
during bilirubin infusion and in phosphatidylcholine-supplemented bile. Un
conjugated bilirubin in bile did not contribute to biliary cytotoxicity. Bi
liary phospholipids were always phosphatidylcholine much greater than phosp
hatidylethanolamine, mainly of C-16:0,C- 18:2 and C-16:0,C- 18:1 fatty acid
configuration. Conclusions: Intravenous bilirubin loads reduce biliary pho
spholipid secretion without changing hepatic P-gp expression. Bilirubin inf
usions increase biliary cytotoxicity by augmenting the biliary bile acid to
phospholipid ratio.